BofA: Bristol update may boost Cytokinetics shares
Go back to BofA: Bristol update may boost Cytokinetics shares| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.83 -0.82 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.65 | 52 Week High | $77.12 | |||
| Open | $64.13 | 52 Week Low | $49.03 | |||
| Day High | $64.33 | P/E | 41.45 | |||
| Day Low | $63.35 | EPS | $1.54 | |||
| Volume | 7,529,798 | |||||
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 74.13 +0.68 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.45 | 52 Week High | $13.18 | |||
| Open | $72.70 | 52 Week Low | $6.00 | |||
| Day High | $74.26 | P/E | N/A | |||
| Day Low | $72.12 | EPS | $-1.24 | |||
| Volume | 1,756,949 | |||||
